Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a second research
Transplant News by Transplant News

Magenta Therapeutics Announces Multiple Presentations Across Stem Cell Transplant Portfolio at The American Society of Hematology (ASH) Annual Meeting

Transplant News Sharing // News from Source www.businesswire.com CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to
Transplant News by Transplant News

TFF Pharmaceuticals – Game-Changing Drug Reformulation Technology (NASDAQ:TFFP)

Transplant News Sharing // News from Source seekingalpha.com TFF Pharma (TFFP) is a small cap pharmaceutical company with an extraordinary amount of irons in the fire. With a novel drug-formulation technology,
Transplant News by Transplant News

Solid Organ Transplant Immunosuppressant Industry Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2026 – Zenit News

Transplant News Sharing // News from Source zenitnews.com A recent market research report added to repository of Credible Markets is an in-depth analysis of “Global Solid Organ Transplant Immunosuppressant Industry Market”.
Transplant News by Transplant News